Prevalence of Co-morbidities and severity of COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 4, 2015, Pages 390-394

  Battaglia, Salvatore ^a   Basile, Marco ^a   Scichilone, Nicola ^a   Bellia, Vincenzo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

co morbidities; COPD; epidemiology; prevalence; systemic effects

Indexed keywords

AGED; AIRWAY OBSTRUCTION; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUTRITIONAL DISORDER; OBESITY; OBSERVATIONAL STUDY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNDERWEIGHT; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84939449516     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.974734     Document Type: Article

References (30)

1. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Euro Respir J 2007; 30 (5): 993-1013
2. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B, Group BC. Co-morbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2012; 186 (2): 155-161
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD (Updated 2009). 2009. p. Available from: http://www.goldcopd.org/
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD (Updated 2013). 2013. p. Available from: http://www.goldcopd.org/
5. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op t Roodt J, Wouters EF, Franssen FM. Clusters of co-morbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2013; 187 (7): 728-735
6. Crisafulli E, Costi S, Luppi F, Cirelli G, Cilione C, Coletti O, Fabbri LM, Clini EM. Role of co-morbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax 2008; 63 (6): 487-492
7. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Force AET. Standardisation of spirometry. Euro Respir J 2005; 26 (2): 319-338
8. Sorino C, Battaglia S, Scichilone N, Pedone C, Antonelli-Incalzi R, Sherrill D, Bellia V. Diagnosis of airway obstruction in the elderly: contribution of the SARA study. Inter J Chron Obstruct Pulmon Dis 2012; 7: 389-7395
9. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England journal of medicine. 2004; 350 (10): 1005-1012
10. Franssen FM, O'Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008; 63 (12): 1110-1117
11. Miller J, Edwards LD, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Vestbo J, Wouters E, Yates JC, Macnee W. Co-morbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 2013; 107 (9): 1376-1384
12. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: An ignored combination? Euro J Heart Fail 2006; 8 (7): 706-711
13. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Euro Respir J 2008; 32 (4): 962-969
14. de Lucas-Ramos P, Izquierdo-Alonso JL, Rodriguez-Gonzalez Moro JM, Frances JF, Lozano PV, Bellon-Cano JM. Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Inter J Chron Obstruct Pulmon Dis 2012; 7: 679-86
15. Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, Speizer FE, Barr RG, Camargo CA Jr. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004; 27 (10): 2478-2484
16. Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V. Chronic renal failure: a neglected co-morbidity of COPD. Chest 2010; 137 (4): 831-837
17. Hanania NA, Mullerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. American journal of respiratory and critical care medicine. 2011; 183 (5): 604-611
18. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proceedings of the American Thoracic Society. 2005; 2 (1): 8-11
19. Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-Aged cohort. Thorax 2008; 63 (7): 599-605
20. Kiechl S, Werner P, Egger G, Oberhollenzer F, Mayr M, Xu Q, Poewe W, Willeit J. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Stroke; J Cereb Circ 2002; 33 (9): 2170-2176
21. Barnes PJ, Celli BR. Systemic manifestations and co-morbidities of COPD. Euro Respir J 2009; 33 (5): 1165-1185
22. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. The European respiratory journal. 2008 Mar;31(3): 492-501
23. Rutten EP, Wouters E, Franssen FM. Malnutrition and obesity in COPD. In: Rabe KF, Wedzicha JA, Wouters E., editors. COPD Co-morbid Euro Respir Soc 2013; 80-92
24. Vozoris NT, O'Donnell DE. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J 2012; 19 (3): e18-24
25. Montes de Oca M, Talamo C, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, Pertuze J, Moreno D, Halbert RJ, Menezes AM, Team P. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. Respir Med 2008; 102 (5): 642-650
26. Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-Analysis. PloS One 2012; 7 (8): e43892
27. Burgel PR, Paillasseur JL, Peene B, Dusser D, Roche N, Coolen J, Troosters T, Decramer M, Janssens W. Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PloS one. 2012; 7 (12): e51048
28. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 1999; 160 (6): 1856-1861
29. Decramer M, Cooper CB. Treatment of COPD: the sooner the better? Thorax 2010; 65 (9): 837-841
30. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122